Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Neural Regulation01:37

Neural Regulation

39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From blood vessels to brain cells: Connecting the circulatory system and Parkinson's disease.

Journal of Parkinson's disease·2025
Same author

ER calcium depletion as a key driver for impaired ER-to-mitochondria calcium transfer and mitochondrial dysfunction in Wolfram syndrome.

Nature communications·2024
Same author

No Evidence of Sensory Neuropathy in a Traditional Mouse Model of Idiopathic Parkinson's Disease.

Cells·2024
Same author

Preclinical trials in Alzheimer's disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice.

PloS one·2023
Same author

Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype.

Cells·2021
Same author

Using Rotenone to Model Parkinson's Disease in Mice: A Review of the Role of Pharmacokinetics.

Chemical research in toxicology·2021

Related Experiment Video

Updated: Jun 6, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.6K

Levodopa Impairs Lysosomal Function in Sensory Neurons In Vitro.

Oyedele J Olaoye1, Asya Esin Aksoy1, Santeri V Hyytiäinen1

  • 1Department of Pharmacology, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia.

Biology
|November 27, 2024
PubMed
Summary

High-dose levodopa, a key Parkinson's disease (PD) treatment, impairs sensory neuron function by affecting mitochondria and lysosomes. These harmful effects on neurons occur independently of homocysteine.

Keywords:
50B11 sensory cell lineParkinson’s diseasedorsal root ganglionlevodopalysosomemitochondriarotenone

More Related Videos

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

2.6K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.5K

Related Experiment Videos

Last Updated: Jun 6, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.6K
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

2.6K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.5K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by motor symptoms.
  • Non-motor symptoms and peripheral neuropathy are increasingly recognized in PD patients.
  • High-dose levodopa, a primary PD treatment, is suspected to induce or worsen neuropathy, potentially via homocysteine.

Purpose of the Study:

  • To investigate the direct effects of levodopa on sensory neurons.
  • To examine levodopa's impact on neuronal morphology, mitochondrial function, and lysosomal activity.
  • To determine if levodopa's effects on sensory neurons are mediated by homocysteine.

Main Methods:

  • Primary cultures of dorsal root ganglia and a sensory neuronal cell line were treated with levodopa.
  • Assessed cell morphology, mitochondrial membrane potential, and lysosomal content and acidity.
  • Investigated the role of homocysteine in levodopa's effects.

Main Results:

  • High-dose levodopa reduced mitochondrial membrane potential in sensory neurons.
  • Levodopa exposure increased beta III tubulin immunoreactivity at patient-relevant concentrations.
  • Levodopa impaired lysosomal function by reducing lysosome content and acidity, independent of homocysteine.

Conclusions:

  • Levodopa, while crucial for Parkinson's disease treatment, exhibits detrimental effects on sensory neurons at therapeutic concentrations.
  • These adverse effects on neuronal function, particularly lysosomal activity, are not attributable to homocysteine.
  • Findings highlight potential mechanisms for levodopa-induced neuropathy in PD patients.